Cargando…
Clinical use of antidepressant therapy and associated cardiovascular risk
A number of different psychotropic agents have been associated with an increased risk of cardiovascular disease, and these relationships have been difficult to interpret due to the presence of confounding factors. Recently, there has been renewed interest in the potential for certain antidepressants...
Autor principal: | Waring, W Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426258/ https://www.ncbi.nlm.nih.gov/pubmed/22936860 http://dx.doi.org/10.2147/DHPS.S28804 |
Ejemplares similares
-
Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review
por: Yekehtaz, Habibeh, et al.
Publicado: (2013) -
Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010) -
Antidepressants and cardiovascular adverse events: A narrative review
por: Nezafati, Mohammad Hassan, et al.
Publicado: (2015) -
Antidepressants as Autophagy Modulators for Cancer Therapy
por: He, Leping, et al.
Publicado: (2023) -
Depression, antidepressants and fall risk: therapeutic dilemmas—a clinical review
por: van Poelgeest, E. P., et al.
Publicado: (2021)